News Focus
News Focus
icon url

Invest83838

11/13/15 9:20 AM

#64597 RE: Mogwai #64591

Mogwai, I Agree with HD


since he has the best economic statistical knowledge concerning Amarin

and especially since the script rates are not increasing very fast.

I really like Sam's "WTF!!!" concerning the larger increase in non-generic Lovaza versus Vascepa.

Maybe reality will start to be acknowledged by those with Rose Colored glasses.